Scotia Capital Inc.

Source: SEC Form 13F · as of Mar 2026

Scotia Capital Inc. holds 46 biotech & pharma companies tracked by BioSniper, totaling $721.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$721.9M

CompanySharesValue
JNJJOHNSON & JOHNSON1,231,920$301.1M
LLYELI LILLY & Co86,840$79.9M
AZNASTRAZENECA PLC211,351$41.7M
UNHUnitedHealth Group Incorporated Common Stock (DE)151,760$41.1M
ABBVAbbVie Inc.183,643$39.9M
PFEPFIZER INC1,058,826$29.7M
MRKMerck & Co., Inc.202,667$24.4M
GMOptec International, Inc.293,644$21.9M
GILDGILEAD SCIENCES, INC.142,932$19.9M
MCKMcKesson Corporation22,839$19.8M
NVONovo Nordisk A/S381,226$14.0M
AMGNAMGEN INC33,751$11.9M
NVSNovartis AG72,553$11.1M
CAHCardinal Health Inc.47,292$10.0M
BMYBRISTOL MYERS SQUIBB CO164,026$9.9M
ELVElevance Health Inc.31,792$9.3M
EPRXEUPRAXIA PHARMACEUTICALS INC.1,342,178$7.2M
PMPhilip Morris International Inc42,366$7.0M
BNTXBioNTech SE45,000$4.0M
ABTABBOTT LABORATORIES38,886$4.0M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)49,891$2.8M
CORCencora Inc.7,055$2.2M
VRTXVERTEX PHARMACEUTICALS INC / MA4,861$2.2M
BIIBBIOGEN INC.6,274$1.2M
LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.283,162$869K
DFTXDefinium Therapeutics Inc.40,548$766K
ZTSZoetis Inc.6,275$742K
ZBHZimmer Biomet Holdings Inc.5,590$505K
IDXXIDEXX LABORATORIES INC /DE883$496K
TEVATeva Pharmaceutical Industries Limited12,564$378K
VTRSViatris Inc27,030$365K
LXRXLEXICON PHARMACEUTICALS, INC.159,831$249K
LGNDLigand Pharmaceuticals Incorporated1,164$232K
VKTXViking Therapeutics, Inc.7,048$229K
GEHCGE HealthCare Technologies Inc.2,848$203K
IRWDIRONWOOD PHARMACEUTICALS INC55,272$194K
OCULOCULAR THERAPEUTIX, INC13,337$113K
EDSAEdesa Biotech, Inc.15,843$83K
MBOTMicrobot Medical Inc.32,876$79K
ABUSArbutus Biopharma Corp14,740$66K
ABCLAbCellera Biologics Inc.16,925$59K
NGENNERVGEN PHARMA CORP.12,998$49K
SNDLSNDL Inc.22,193$29K
CGCCanopy Growth Corp23,540$22K
LCTXLineage Cell Therapeutics, Inc.10,000$16K
ALTSALT5 Sigma Corp10,000$11K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Scotia Capital Inc. — Biotech 13F Holdings & Portfolio | BioSniper